Ten new officially confirmed cases of the novel coronavirus (COVID-19) were reported in Tajikistan on January 31, the Ministry of Health and Social Protection of the Population (MoHSPP) says.
A number of officially confirmed cases of COVID-19 reported in Tajikistan since January 21 has reached 223.
A total number of the officially confirmed cases of COVID-19 infection in Tajikistan has reached 17,318 since April 30, 2020, when its index cases were confirmed in the country.
The number of the officially confirmed coronavirus-linked deaths in Tajikistan has remained the same – 124.
A MoHSPP says a total number of those who have been cured in Tajikistan since April 30, 2020 has reached 17,096 (98.8 percent).
The COVID-19 pandemic in Tajikistan is part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The virus was confirmed to have spread to Tajikistan when its index cases, in Dushanbe and Khujand, were confirmed on 30 April 2020.
By January 13, 2021, government reported that all cases had either recovered or died, leaving the country free of COVID-19 for the first time since April 2020. Tajikistan reported to be the first country in Central Asia to eradicate COVID-19, and would be the only country with over 10,000 total cases to have zero active cases. After five months and twelve days, Tajikistan recorded 63 news COVID-19 cases.
Meanwhile, a COVID-19 vaccination campaign is under way in Tajikistan. According to official data, 4,312,774 people have been vaccinated in the country as of January 20, 2022.
In Tajikistan, COVID-19 vaccination is compulsory for people aged 18 and over; in all, 5,826,301 people in Tajikistan must be vaccinated against COVID-19.
A COVID-19 revaccination campaign has also been launched in Tajikistan.
Revaccination is the act of administering a vaccine again some period after an initial vaccination especially to strengthen or renew the immune response
In Tajikistan, five types of the COVID-19 vaccine are used for vaccination of the population: CoronaVac; AstraZeneca; Moderna; Pfizer; and Sputnik V.
